Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.

Vin-Raviv N, Akinyemiju T, Meng Q, Sakhuja S, Hayward R.

Cancer Med. 2017 Jan;6(1):320-329. doi: 10.1002/cam4.968. Epub 2016 Nov 28.

2.

Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic.

Gentes EL, Schry AR, Hicks TA, Clancy CP, Collie CF, Kirby AC, Dennis MF, Hertzberg MA, Beckham JC, Calhoun PS.

Psychol Addict Behav. 2016 May;30(3):415-21. doi: 10.1037/adb0000154.

PMID:
27214172
3.

Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.

Khullar V, Jain A, Sattari M.

J Gen Intern Med. 2014 Aug;29(8):1200-4. doi: 10.1007/s11606-014-2802-4. Epub 2014 Feb 20. Review.

4.

Subarachnoid hemorrhage from a thoracic radicular artery pseudoaneurysm after methamphetamine and synthetic cannabinoid abuse: case report.

Ray WZ, Krisht KM, Schabel A, Schmidt RH.

Global Spine J. 2013 Jun;3(2):119-24. doi: 10.1055/s-0032-1331463. Epub 2012 Dec 6.

5.

Acute intoxication caused by a synthetic cannabinoid in two adolescents.

Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW.

J Pediatr Pharmacol Ther. 2012 Apr;17(2):177-81. doi: 10.5863/1551-6776-17.2.177.

6.

Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard.

Esse K, Fossati-Bellani M, Traylor A, Martin-Schild S.

Brain Behav. 2011 Sep;1(1):44-54. doi: 10.1002/brb3.7.

7.

Identifying risk factors for marijuana use among veterans affairs patients.

Goldman M, Suh JJ, Lynch KG, Szucs R, Ross J, Xie H, O'Brien CP, Oslin DW.

J Addict Med. 2010 Mar;4(1):47-51. doi: 10.1097/ADM.0b013e3181b18782.

Supplemental Content

Support Center